USPTO serial 87301043
LONGEVIA GENOMICS
Reviewed by CopyMark Law Group
Reg. 5711986Status 710
- Filing date
- Status date
- Registration date
- Apr 2, 2019
- Examiner
- MIDDLETON, BERNICE L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LONGEVIA GENOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark A. Jansen
Mark A. Jansen Fenwick & West LLP801 California StreetSilicon Valley CenterMountain View, CA 94041Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of diseases, disorders and conditions in the fields of oncology and immunology; veterinary preparations for treatment and prevention of diseases, disorders and conditions in the fields of oncology and immunology; sanitary preparations for medical purposes; diagnostic preparations for medical purposes; reagents for use in diagnostic tests for medical use; chemical diagnostic reagents for medical use; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical test reagents, namely, for use in testing and evaluating DNA, genetics, and biological specimens clinical diagnostic reagents, namely, for use in testing and evaluating DNA, genetics, and biological specimens; clinical medical reagents; contrast media for use in medical imaging; diagnostic agents for medical use; diagnostic testing materials, namely, reagents and assays for testing DNA, genetics and biological specimens for medical use; genetic identity tests comprised of reagents for medical purposes; medical diagnostic test strips for testing DNA, genetics and biological specimens; indicators, namely, strips, pellets, films and liquids for medical diagnosis, namely, chemical, biological and genetic indicators for medical diagnosis; genetic identity tests comprised of reagents for medical purposes | SECTION 8 - CANCELLED | — |
| 010 | Apparatus for use in medical analysis of DNA, genetics and biological specimens; apparatus for carrying-out diagnostic tests for medical purposes for testing DNA, genetics and biological specimens; diagnostic apparatus for medical purposes for testing and analyzing DNA, genetics and biological specimens; medical diagnostic instruments for detecting diseases, disorders and conditions in oncology and immunology; blood testing apparatus; medical and veterinary apparatus and instruments, namely, testing apparatus for testing DNA, genetics and biological specimens; medical apparatus for taking body fluid samples; medical apparatus for tumor diagnosis; automated medical analyzers for body fluids; medical diagnostic, examination, and monitoring equipment, namely, apparatus for DNA testing for identifying, preventing and managing diseases, disorders and conditions for medical purposes in the fields of oncology and immunology; filters for blood and blood components for medical purposes; fluid collection containers for medical use; medical instruments for extracting human body fluids; electronic analyzers for medical purposes for analyzing DNA, genetics and biological specimens; automated medical analyzers for foreign matter contained in body fluids; automatic analyzers for medical diagnosis of diseases, disorders and conditions in the fields of oncology and immunology; electromedical diagnostic instruments for testing DNA, genetics and biological specimens; genetic testing apparatus for medical purposes | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services, namely, management and analysis, namely, genomics management and analysis of biorepository data; scientific services, namely, medical and scientific research in the field of genetics, pharmaceuticals, oncology, and immunology and research and design relating thereto; industrial analysis and research services in the fields of medicine, genetics and pharmaceuticals; development of computer hardware and software; research relating to molecular sciences; scientific analysis in the field of molecular biology; medical research; medical laboratory services; medical and pharmacological research services; scientific research for medical purposes on biorepository data in the field of genetics, pharmaceuticals, oncology and immunology; design and development of medical technology; computer programming in the medical field analysis of human tissues for medical research; biological research, clinical research on biorepository data in the field of genetics, pharmaceuticals, oncology and immunology; medical research; design and development of medical diagnostic apparatus; scientific research for medical purposes in the area of cancerous diseases; provision of information and data relating to medical and veterinary research and development; microbiological testing in the field of diseases, disorders and conditions in the fields of oncology and immunology; biotechnology testing in the field of diseases, disorders and conditions in the fields of oncology and immunology; laboratory testing in the field of diseases, disorders and conditions in the fields of oncology and immunology; scientific research and testing services in the fields of bacteriology and virology; genetic scientific research; genetic engineering services; DNA screening for scientific research purposes; medical laboratory services, namely, laboratory analysis services relating to the treatment of persons, namely, testing and analysis of biorepository data, DNA, genetics and biological specimens | SECTION 8 - CANCELLED | — |
| 044 | Medical services; genetic counseling; health screening services for diseases, disorders and conditions in the fields of oncology and immunology; providing health information; performing diagnosis of diseases; RNA or DNA services analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; medical and health care services relating to DNA, genetics and genetic testing; DNA screening for medical purposes | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LonGevia Genomics Srl
- Other trademarks owned by LonGevia Genomics Srl
- Other trademarks owned by LonGevia Genomics Srl
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LONGEVIA GENOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 17, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 1, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 1, 2025 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Oct 1, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 29, 2025 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| May 29, 2025 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Apr 2, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 4, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 4, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 4, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 2, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 15, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 11, 2018 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Dec 7, 2018 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Dec 3, 2018 | DMCC | DATA MODIFICATION COMPLETED | — |
| Dec 3, 2018 | PBIC | WITHDRAWN FROM PUB - INCOMING CORR RECEIVED | — |
| Nov 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 15, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 16, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 16, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 16, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 27, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 8, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 8, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 8, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 10, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 17, 2017 | NWAP | NEW APPLICATION ENTERED | — |